However, I know that discussions are on-going, and I know that the SMC is collaborating with NICE on a joint multiple-technology appraisal of several cystic fibrosis medicines, including Kaftrio. The SMC will publish final recommendations, aligned with NICE guidance, for health boards in Scotland to consider.